Relievant Medsystems Receives 2023 Gallup Exceptional Workplace Award
MINNEAPOLIS, March 30, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that it has received the 2023 Gallup Exceptional Workplace Award (GEWA) which recognizes highly engaged workplace cultures. Gallup found that Relievant continues to put employee engagement at the center of the company’s business strategy.
“An active and engaging workplace culture serves as the foundation for our vision to provide life-changing relief to patients,” said Tyler Binney, President and CEO of Relievant Medsystems. “We are dedicated to building an organization where employees can thrive and meaningfully contribute as we transform the diagnosis and treatment of chronic vertebrogenic low back pain.”
Gallup’s meta-analysis on team engagement and performance is the most comprehensive workplace study ever conducted, with data on more than 2 million employees in 276 organizations across 54 industries and 96 countries. Highly engaged organizations have outperformed their peers in business outcomes, including customer ratings, profitability, productivity, turnover, safety incidents, shrinkage, absenteeism, quality, wellbeing and organizational citizenship.
“Gallup’s 2023 GEWA winners proved that even during some of the most challenging times, strong cultures are resilient and find new ways to get work done and meet customer needs. These organizations continued to make employee engagement a central cultural priority as part of their business strategy, and they maintained record levels of employee engagement while achieving or exceeding their business goals,” said Jim Harter, Gallup’s chief scientist of workplace management and wellbeing.
Relievant Medsystems’ minimally invasive Intracept® Procedure is the only FDA-cleared treatment for chronic vertebrogenic low back pain, using targeted radiofrequency energy to stop the BVN from transmitting pain signals to the brain. The procedure is typically performed in an outpatient surgery center and takes approximately one hour. Based on existing data, patients typically experience minimal post-procedure pain and generally quick recovery times. Patients often feel pain relief within two weeks of being treated with the Intracept Procedure.
About Vertebrogenic Pain
Of the 30 million people in the U.S. with chronic low back pain, 1 in 6 are likely to have vertebrogenic pain, a distinct type of chronic low back pain caused by damage to vertebral endplates, the interface between the disc and the vertebral body. Patients typically have pain in the middle of their low back, which worsens when they bend over, sit for long periods of time, or when they are active. A physician can confirm a patient’s pain is vertebrogenic by observing Modic changes, a biomarker seen on standard MRI that indicates inflammation at the vertebral endplate.
About Relievant Medsystems
Relievant Medsystems is a commercial-stage medical device company transforming the diagnosis and treatment of vertebrogenic pain, a form of Chronic Low Back Pain (CLBP), with the Intracept Procedure – a novel, clinically proven and commercially available treatment designed to improve the quality of life for millions of indicated patients. For more information about Relievant Medsystems and the Intracept Procedure, visit www.relievant.com.
About Gallup and the 2023 Gallup Exceptional Workplace Award
Gallup delivers analytics and advice to help leaders and organizations solve their most pressing problems. Combining more than 80 years of experience with its global reach, Gallup knows more about the attitudes and behaviors of employees, customers, students and citizens than any other organization in the world.
GEWA winners’ ratio of engaged employees to actively disengaged employees is 16 times higher than the international average. Worldwide, only 21% of employees are engaged — that is, committed to their work and connected to their workplace — and just 32% of employees in the U.S. workforce are engaged. Seventy-two percent of employees at winning GEWA organizations are engaged. For a complete list of GEWA winners and more about the selection process, visit the winners’ page.
Media Contact:
Shelli Lissick, Bellmont Partners
(651) 276-6922 | shelli@bellmontpartners.com
Investor Contact:
Marissa Bych, Gilmartin Group
(805) 305-1244 | marissa@gilmartinir.com
